# Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties

> **NCT00679900** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 283 (actual)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** eplivanserin (SR46349)
- **DRUG:** lormetazepam

## Key facts

- **NCT ID:** NCT00679900
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 283 (ACTUAL)
- **Last updated:** 2010-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00679900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00679900, "Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance Difficulties". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00679900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*